Research on dolutegravir-based therapy for hiv suggests that the persistence of the virus in tissues is not due to resistance mutations to the drug. Studies have also explored the effects of dolutegravir on the gut microbiota and its potential impact on other health aspects, such as inflammation and cardiovascular issues. The findings appear to be part of a broader investigation into the mechanisms and implications of hiv treatment with dolutegravir.